Detalhe da pesquisa
1.
Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial.
BMC Ophthalmol
; 23(1): 121, 2023 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36973703